对反复种植失败女性进行自体富血小板血浆宫腔灌注是否合理?
本文综述了13项随机对照试验和11项Meta分析,探讨自体富血小板血浆宫腔灌注对反复种植失败女性妊娠率的影响。现有Meta分析支持妊娠率提高,但原始临床研究质量低且可信度存疑,反复种植失败定义不一致限制了结果合并与外推。ESHRE已发布基于证据的反复种植失败定义,但按此定义尚未有研究明确评估该干预。当前证据不足以指导临床实践,需设计良好的研究提供更清晰指引。
要点
- 13项RCT和11项Meta分析支持宫腔灌注自体富血小板血浆提高反复种植失败患者妊娠率。
- 原始临床研究质量低且可信度存疑,无法得出确定性结论。
- ESHRE已发布反复种植失败循证定义,但按此定义尚无研究明确评估该干预。
核心结论
- 现有证据不足以指导临床实践,需设计良好的研究提供更清晰指引。
研究设计与样本
- 本文为综述,汇总了13项随机对照试验和11项Meta分析,评估自体富血小板血浆宫腔灌注对反复种植失败女性的疗效。
主要发现
- 这些Meta分析支持宫腔灌注自体富血小板血浆后妊娠率提高。
- 现有原始临床研究质量低且可信度存疑,严重质疑其内部有效性,无法得出确定性结论。
- 各研究采用的反复种植失败定义存在变异性,限制了外部有效性,使结果合并困难,并总体 complicating 已发表结果的外推。
关键数值与推荐
- ESHRE近期发布了基于证据的反复种植失败定义,以促进对这些患者干预措施的评估。
- 按ESHRE定义识别出真实临床问题,但已发表文献中尚未明确在反复种植失败患者中评估宫腔灌注自体富血小板血浆。
临床怎么用
- 当前证据不足以指导临床实践。
- 宫腔灌注自体富血小板血浆改善反复种植失败女性结局的潜力仍是辅助生殖技术中的重要研究领域。
局限性
- 现有原始临床研究质量低。
- 对原始临床研究可信度的担忧严重质疑其内部有效性。
- 各研究采用的反复种植失败定义存在变异性,限制了外部有效性并使结果合并困难。
- 已发表文献中尚未按ESHRE定义明确在反复种植失败患者中评估宫腔灌注自体富血小板血浆。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, an increased interest in the efficacy of intrauterine infusion of autologous platelet-rich plasma (PRP) in women with repeated implantation failure (RIF) has resulted in the publication of 13 randomized controlled trials (RCTs) and 11 meta-analyses. Although these meta-analyses support an increase in pregnancy rates after intrauterine infusion of autologous PRP, the low quality of the available original clinical studies along with concerns regarding their trustworthiness seriously questions their internal validity and does not allow for definitive conclusions to be drawn. In addition, the variability in the definition of RIF used in the individual studies limits their external validity, renders the pooling of the results problematic, and, overall, complicates the extrapolation of the results published. The variability in the definition of RIF has been recently addressed by the ESHRE, which published an evidence-based definition of RIF to facilitate the evaluation of interventions in these patients. Taking into consideration this definition, which identifies a real clinical problem, evaluation of intrauterine infusion of PRP in the published literature has not so far been performed explicitly in patients with RIF. The potential of intrauterine infusion of autologous PRP to improve outcomes for women with RIF remains an important area of research in ART. However, the current evidence is insufficient to inform clinical practice, highlighting the need for well-designed studies to provide clearer guidance.
引用
- Katsika ET, Venetis CA, Bosdou JK, et al. Is it justified to offer intrauterine infusion of autologous PRP in women with repeated implantation failure? Hum Reprod. 2025. PMID: 40096626. doi:10.1093/humrep/deaf014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。